Key result
Bipolar disorder linked to ~94% higher risk of composite cardiometabolic diseases versus controls.
Why the study?
The association of bipolar disorder with cardiometabolic diseases and premature death in Asians required further determination, with relatively little attention paid to heart failure.
Does bipolar disorder increase the risk of cardiometabolic diseases, heart failure, and all-cause mortality in adults without baseline cardiometabolic disease?
Cohort (n=22,658)
Does bipolar disorder increase the risk of cardiometabolic diseases, heart failure, and all-cause mortality in adults without baseline cardiometabolic disease?
Hazard Ratio: 1.939 (95% CI 1.86–2.022)
Absolute Event Rate: 85.1% vs 46.4%
p-value: p=<0.0001
Bipolar disorder is associated with a significantly increased risk of incident cardiometabolic diseases, heart failure hospitalization, and all-cause mortality in an Asian population, highlighting the need for intensified cardiovascular screening in this group.
Bipolar disorder was associated with higher cardiometabolic risk; leaves open whether screening improves outcomes.
The association of bipolar disorder (BD) with the risk of cardiometabolic diseases and premature death in Asians needs to be further determined. Relatively less attention has been paid to heart failure (HF) among cardiometabolic outcomes. We analyzed the Korean National Health Insurance Service database (2002-2018) for this population-based, matched cohort study. The hazards of ischemic stroke, ischemic heart disease (IHD), hospitalization for HF (hHF), composite cardiometabolic diseases, and all-cause mortality during follow-up were compared between individuals with BD (n = 11,329) and 1:1-matched controls without psychiatric disorders among adults without cardiometabolic disease before or within 3 months of baseline. Hazards of outcomes were higher in individuals with BD than in matched controls (adjusted hazard ratios [95% confidence intervals]: 1.971 [1.414-2.746] for ischemic stroke, 1.553 [1.401-1.721] for IHD, 2.526 [1.788-3.567] for hHF, 1.939 [1.860-2.022] for composite cardiometabolic diseases, and 2.175 [1.875-2.523] for all-cause mortality) during follow-up. Associations between BD and outcome hazards were more prominent in younger individuals (p for interaction < 0.02, except for ischemic stroke) and women (p for interaction < 0.04, except for hHF). Screening and preventive measures for cardiometabolic deterioration and early mortality may need to be intensified in individuals with BD, even in young adults, especially women.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) conducted a cohort in Bipolar disorder (n=22,658). Bipolar disorder vs. Matched controls without major psychiatric disorders was evaluated on Composite of all cardiometabolic diseases (HR 1.939, 95% CI 1.860-2.022, p=<0.0001). Bipolar disorder increased the risk of composite cardiometabolic diseases by 94% (HR 1.939) compared to matched controls without psychiatric disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: